vs

Side-by-side financial comparison of CREATIVE REALITIES, INC. (CREX) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $23.9M, roughly 1.6× CREATIVE REALITIES, INC.). On growth, CREATIVE REALITIES, INC. posted the faster year-over-year revenue change (117.2% vs -57.1%). Over the past eight quarters, CREATIVE REALITIES, INC.'s revenue compounded faster (39.5% CAGR vs -46.5%).

Creative Realities, Inc. is a provider of end-to-end immersive digital experience solutions, including interactive digital signage, content management software, and custom experiential design services. It primarily caters to retail, hospitality, healthcare, corporate workplace, and public sector clients across North America, helping brands enhance customer engagement and operational efficiency.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CREX vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.6× larger
ORGO
$37.2M
$23.9M
CREX
Growing faster (revenue YoY)
CREX
CREX
+174.3% gap
CREX
117.2%
-57.1%
ORGO
Faster 2-yr revenue CAGR
CREX
CREX
Annualised
CREX
39.5%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CREX
CREX
ORGO
ORGO
Revenue
$23.9M
$37.2M
Net Profit
$-2.0M
Gross Margin
47.9%
30.8%
Operating Margin
1.9%
-185.1%
Net Margin
-8.2%
Revenue YoY
117.2%
-57.1%
Net Profit YoY
30.8%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CREX
CREX
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$23.9M
$225.6M
Q3 25
$10.5M
$150.9M
Q2 25
$13.0M
$101.0M
Q1 25
$9.7M
$86.7M
Q4 24
$11.0M
$126.7M
Q3 24
$14.4M
$115.2M
Q2 24
$13.1M
$130.2M
Net Profit
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
$-2.0M
$43.7M
Q3 25
$-7.9M
$21.6M
Q2 25
$-1.8M
$-9.4M
Q1 25
$3.4M
$-18.8M
Q4 24
$-2.8M
$7.7M
Q3 24
$54.0K
$12.3M
Q2 24
$-615.0K
$-17.0M
Gross Margin
CREX
CREX
ORGO
ORGO
Q1 26
30.8%
Q4 25
47.9%
Q3 25
45.3%
Q2 25
38.5%
Q1 25
45.7%
72.6%
Q4 24
44.2%
75.5%
Q3 24
45.6%
76.7%
Q2 24
51.8%
77.6%
Operating Margin
CREX
CREX
ORGO
ORGO
Q1 26
-185.1%
Q4 25
1.9%
28.1%
Q3 25
-68.9%
13.7%
Q2 25
-10.2%
-12.5%
Q1 25
-7.4%
-30.9%
Q4 24
-6.5%
8.1%
Q3 24
7.9%
5.4%
Q2 24
4.5%
-10.7%
Net Margin
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
-8.2%
19.4%
Q3 25
-74.5%
14.3%
Q2 25
-13.9%
-9.3%
Q1 25
34.6%
-21.7%
Q4 24
-25.8%
6.1%
Q3 24
0.4%
10.7%
Q2 24
-4.7%
-13.1%
EPS (diluted)
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
$0.31
Q3 25
$-0.75
$0.11
Q2 25
$-0.17
$-0.10
Q1 25
$0.32
$-0.17
Q4 24
$-0.28
$0.05
Q3 24
$0.01
$0.09
Q2 24
$-0.06
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CREX
CREX
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$1.6M
$91.4M
Total DebtLower is stronger
$44.0M
Stockholders' EquityBook value
$21.5M
Total Assets
$151.0M
$520.0M
Debt / EquityLower = less leverage
2.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CREX
CREX
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$1.6M
$93.7M
Q3 25
$314.0K
$63.7M
Q2 25
$569.0K
$73.1M
Q1 25
$1.1M
$110.0M
Q4 24
$1.0M
$135.6M
Q3 24
$868.0K
$94.3M
Q2 24
$4.1M
$89.9M
Total Debt
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
$44.0M
Q3 25
$22.0M
Q2 25
$19.9M
Q1 25
$23.0M
Q4 24
$13.0M
Q3 24
$10.7M
$62.3M
Q2 24
$13.6M
$63.8M
Stockholders' Equity
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
$21.5M
$300.1M
Q3 25
$21.9M
$255.1M
Q2 25
$29.4M
$233.2M
Q1 25
$29.9M
$242.9M
Q4 24
$25.5M
$262.9M
Q3 24
$28.3M
$278.5M
Q2 24
$28.2M
$263.5M
Total Assets
CREX
CREX
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$151.0M
$598.7M
Q3 25
$61.3M
$509.8M
Q2 25
$63.7M
$461.1M
Q1 25
$67.0M
$467.4M
Q4 24
$65.2M
$497.9M
Q3 24
$67.6M
$446.3M
Q2 24
$69.6M
$443.2M
Debt / Equity
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
2.04×
Q3 25
1.00×
Q2 25
0.68×
Q1 25
0.77×
Q4 24
0.51×
Q3 24
0.38×
0.22×
Q2 24
0.48×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CREX
CREX
ORGO
ORGO
Operating Cash FlowLast quarter
$-4.5M
Free Cash FlowOCF − Capex
$-4.6M
FCF MarginFCF / Revenue
-19.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
$-4.5M
$39.4M
Q3 25
$-1.6M
$3.1M
Q2 25
$773.0K
$-32.9M
Q1 25
$-2.4M
$-19.9M
Q4 24
$-1.4M
$10.9M
Q3 24
$544.0K
$8.7M
Q2 24
$2.3M
$4.7M
Free Cash Flow
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
$-4.6M
$34.8M
Q3 25
$-1.7M
$844.0K
Q2 25
$672.0K
$-36.5M
Q1 25
$-2.5M
$-23.6M
Q4 24
$-1.4M
$7.6M
Q3 24
$543.0K
$6.1M
Q2 24
$2.3M
$2.9M
FCF Margin
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
-19.1%
15.4%
Q3 25
-16.2%
0.6%
Q2 25
5.2%
-36.1%
Q1 25
-25.2%
-27.2%
Q4 24
-12.5%
6.0%
Q3 24
3.8%
5.3%
Q2 24
17.3%
2.2%
Capex Intensity
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
0.4%
2.1%
Q3 25
1.0%
1.5%
Q2 25
0.8%
3.6%
Q1 25
0.1%
4.2%
Q4 24
0.0%
2.7%
Q3 24
0.0%
2.2%
Q2 24
0.0%
1.4%
Cash Conversion
CREX
CREX
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
-0.73×
Q4 24
1.43×
Q3 24
10.07×
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CREX
CREX

Service And Other$17.3M72%
Managed Services$4.7M20%
Installation Services$1.7M7%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons